LIVE
Home
Politics
Business
Opinion
Technology
Lifestyle
Entertainment
Video
Cashing in on coronavirus: Small biopharma company NanoViricides sees stock soar on treatment claims
Business
July 14, 2020
This article is being updated.
Previous article: 3M partners with MIT researchers to develop U.S.-backed rapid coronavirus antigen test
Prev
Next article: Burger King is selling a burger made from cows on low-methane diet
Next
via
CNBC
July 14th 2020
MixedTimes.com
Business
Cashing in on coronavirus: Small biopharma company NanoViricides sees stock soar on treatment claims
Home
Politics
Business
Opinion
Technology
Lifestyle
Entertainment
Video